Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension.

Desole S, Richter MJ, Heine A, Ewert R.

Pulm Circ. 2019 Jan-Mar;9(1):2045894018788846. doi: 10.1177/2045894018788846. Epub 2018 Jun 26.

2.

[Lung Health Data of the Study of Health in Pomerania - a Review of Samples, Methods and First Results].

Ewert R, Ittermann T, Bollmann T, Spielhagen T, Dörr M, Schäper C, Warnke C, Obst A, Friedrich N, Felix SB, Markus MR, Piontek M, Penzel T, Fietze I, Glos M, Stubbe B, Desole S, Kaczmarek S, Schmidt CO, Völzke H, Gläser S.

Pneumologie. 2017 Jan;71(1):17-35. doi: 10.1055/s-0042-117461. Epub 2017 Jan 23. Review. German.

PMID:
28114706
3.

Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.

Desole S, Velik-Salchner C, Fraedrich G, Ewert R, Kähler CM.

Heart Lung. 2012 Nov-Dec;41(6):599-605. doi: 10.1016/j.hrtlng.2012.07.001. Epub 2012 Aug 21.

PMID:
22920608
4.

Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.

Kähler CM, Graziadei I, Vogelsinger H, Desole S, Cima K, Vogel W.

Wien Klin Wochenschr. 2011 Apr;123(7-8):248-52. doi: 10.1007/s00508-011-1540-4. Epub 2011 Mar 31.

PMID:
21451953
5.

[Decompensated pulmonary hypertension].

Desole S, Kähler CM.

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S215-8. doi: 10.1055/s-0028-1091243. Epub 2008 Sep 23. Review. German.

PMID:
18814101
6.

Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.

Marchetti B, Serra PA, Tirolo C, L'episcopo F, Caniglia S, Gennuso F, Testa N, Miele E, Desole S, Barden N, Morale MC.

Brain Res Brain Res Rev. 2005 Apr;48(2):302-21. Review.

PMID:
15850669

Supplemental Content

Loading ...
Support Center